Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Conditions: Type 2 Diabetes Interventions: Drug: DA5221-T1; Drug: DA5221-T2; Drug: Placebo; Drug: DA5221-B1; Drug: DA5221-B2 Sponsors: Dong-A ST Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials